File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1093/ndt/6.12.944
- Scopus: eid_2-s2.0-0026340907
- PMID: 1724691
- WOS: WOS:A1991HC91100006
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Hepatitis C infection among dialysis patients: A comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis
Title | Hepatitis C infection among dialysis patients: A comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis |
---|---|
Authors | |
Keywords | Haemodialysis Hepatitis C Peritoneal dialysis Transfusion |
Issue Date | 1991 |
Publisher | Oxford University Press. The Journal's web site is located at http://ndt.oxfordjournals.org/ |
Citation | Nephrology Dialysis Transplantation, 1991, v. 6 n. 12, p. 944-947 How to Cite? |
Abstract | Three hundred and thirty-nine dialysis patients from two centres (278 patients on continuous ambulatory peritoneal dialysis (CAPD) and 61 on maintenance haemodialysis (HD) were tested for antibody against hepatitis C virus (anti-HCV) using first-generation enzyme immunoassay kits (Ortho Diagnostics). Anti-HCV was detected in five (1.8%) CAPD patients and ten (16.4%) HD patients (P<0.00001). Anti-HCV was confirmed to be positive in three (1.1%) CAPD patients and eight (13.2%) HD patients using neutralisation enzyme immunoassay kits (Abbott Laboratories). The marked difference in prevalence of anti-HCV among CAPD and HD patients was related to a significantly greater transfusion requirement of the HD patients. All the anti-HCV positive patients had been transfused. The risk of HCV infection was significantly increased in those who had received more than five units of blood. Four (26.7%) anti-HCV positive patients had one or more episodes of elevated serum alanine aminotransferase (ALT) values. |
Persistent Identifier | http://hdl.handle.net/10722/161909 |
ISSN | 2023 Impact Factor: 4.8 2023 SCImago Journal Rankings: 1.414 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, TM | en_US |
dc.contributor.author | Lok, ASF | en_US |
dc.contributor.author | Cheng, IKP | en_US |
dc.date.accessioned | 2012-09-05T05:15:58Z | - |
dc.date.available | 2012-09-05T05:15:58Z | - |
dc.date.issued | 1991 | en_US |
dc.identifier.citation | Nephrology Dialysis Transplantation, 1991, v. 6 n. 12, p. 944-947 | en_US |
dc.identifier.issn | 0931-0509 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/161909 | - |
dc.description.abstract | Three hundred and thirty-nine dialysis patients from two centres (278 patients on continuous ambulatory peritoneal dialysis (CAPD) and 61 on maintenance haemodialysis (HD) were tested for antibody against hepatitis C virus (anti-HCV) using first-generation enzyme immunoassay kits (Ortho Diagnostics). Anti-HCV was detected in five (1.8%) CAPD patients and ten (16.4%) HD patients (P<0.00001). Anti-HCV was confirmed to be positive in three (1.1%) CAPD patients and eight (13.2%) HD patients using neutralisation enzyme immunoassay kits (Abbott Laboratories). The marked difference in prevalence of anti-HCV among CAPD and HD patients was related to a significantly greater transfusion requirement of the HD patients. All the anti-HCV positive patients had been transfused. The risk of HCV infection was significantly increased in those who had received more than five units of blood. Four (26.7%) anti-HCV positive patients had one or more episodes of elevated serum alanine aminotransferase (ALT) values. | en_US |
dc.language | eng | en_US |
dc.publisher | Oxford University Press. The Journal's web site is located at http://ndt.oxfordjournals.org/ | en_US |
dc.relation.ispartof | Nephrology Dialysis Transplantation | en_US |
dc.subject | Haemodialysis | - |
dc.subject | Hepatitis C | - |
dc.subject | Peritoneal dialysis | - |
dc.subject | Transfusion | - |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Hepacivirus - Immunology | en_US |
dc.subject.mesh | Hepatitis Antibodies - Blood | en_US |
dc.subject.mesh | Hepatitis C - Epidemiology - Etiology - Immunology | en_US |
dc.subject.mesh | Hepatitis C Antibodies | en_US |
dc.subject.mesh | Hong Kong - Epidemiology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Peritoneal Dialysis, Continuous Ambulatory - Adverse Effects | en_US |
dc.subject.mesh | Renal Dialysis - Adverse Effects | en_US |
dc.title | Hepatitis C infection among dialysis patients: A comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis | en_US |
dc.type | Article | en_US |
dc.identifier.email | Chan, TM:dtmchan@hku.hk | en_US |
dc.identifier.authority | Chan, TM=rp00394 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1093/ndt/6.12.944 | - |
dc.identifier.pmid | 1724691 | - |
dc.identifier.scopus | eid_2-s2.0-0026340907 | en_US |
dc.identifier.volume | 6 | en_US |
dc.identifier.issue | 12 | en_US |
dc.identifier.spage | 944 | en_US |
dc.identifier.epage | 947 | en_US |
dc.identifier.isi | WOS:A1991HC91100006 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Chan, TM=7402687700 | en_US |
dc.identifier.scopusauthorid | Lok, ASF=35379868500 | en_US |
dc.identifier.scopusauthorid | Cheng, IKP=7102537483 | en_US |
dc.identifier.issnl | 0931-0509 | - |